L FORMS OF STAPHYLOCOCCUS AUREUS.
D000900:Anti-Bacterial Agents; D001414:Bacitracin; D002701:Chloramphenicol; D003091:Colistin; D003470:Culture Media; D003523:Cycloserine; D004352:Drug Resistance, Microbial; D004917:Erythromycin; D005672:Fusidic Acid; D007612:Kanamycin; D007740:L Forms; D008712:Methicillin; D009355:Neomycin; D009675:Novobiocin; D010400:Penicillin G; D010403:Penicillin Resistance; D012106:Research; D012310:Ristocetin; D013203:Staphylococcal Infections; D013210:Staphylococcus; D013204:Staphylococcus Phages; D013211:Staphylococcus aureus; D013307:Streptomycin; D013449:Sulfonamides; D013752:Tetracycline; D014640:Vancomycin
D000900:Anti-Bacterial Agents; D003470:Culture Media; D013449:Sulfonamides; D012310:Ristocetin; D001414:Bacitracin; D009675:Novobiocin; D007612:Kanamycin; D005672:Fusidic Acid; D004917:Erythromycin; D002701:Chloramphenicol; D014640:Vancomycin; D003523:Cycloserine; D013752:Tetracycline; D009355:Neomycin; D010400:Penicillin G; D008712:Methicillin; D013307:Streptomycin; D003091:Colistin
ANTIBIOTICS; BACITRACIN; CHLORAMPHENICOL; COLISTIN; CULTURE MEDIA; CYCLOSERINE; DRUG RESISTANCE, MICROBIAL; ERYTHROMYCIN; EXPERIMENTAL LAB STUDY; FUSIDIC ACID; KANAMYCIN; METHICILLIN; NEOMYCIN; NOVOBIOCIN; PENICILLIN G; PENICILLIN RESISTANCE; RISTOCETIN; STAPHYLOCOCCAL PHAGES; STAPHYLOCOCCUS; STREPTOMYCIN; SULFONAMIDES; TETRACYCLINE; VANCOMYCIN